- Investing Ideas
- /
- Chinese Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Chinese Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
14
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
14 companies
Xiamen Amoytop Biotech
Market Cap: CN¥30.5b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥74.76
7D
-1.3%
1Y
21.9%
Tonghua Dongbao Pharmaceutical
Market Cap: CN¥14.5b
Researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China.
600867
CN¥7.52
7D
3.4%
1Y
-29.0%
Suzhou Zelgen BiopharmaceuticalsLtd
Market Cap: CN¥27.2b
Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
688266
CN¥100.78
7D
0.8%
1Y
88.7%
Shanghai OPM Biosciences
Market Cap: CN¥4.6b
Provides cell culture media and CDMO services in China and internationally.
688293
CN¥40.72
7D
-0.2%
1Y
22.1%
AcrobiosystemsLtd
Market Cap: CN¥5.6b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions.
301080
CN¥47.08
7D
9.1%
1Y
25.4%
Zhejiang Wolwo Bio-Pharmaceutical
Market Cap: CN¥10.4b
A biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally.
300357
CN¥19.81
7D
-0.6%
1Y
-16.4%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥8.5b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥15.25
7D
6.2%
1Y
41.3%
Betta Pharmaceuticals
Market Cap: CN¥20.9b
Researches and develops, manufactures, and markets medicines for the treatment of cancer in China.
300558
CN¥51.20
7D
3.4%
1Y
26.3%
Zhejiang Tianyu Pharmaceutical
Market Cap: CN¥7.1b
Engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally.
300702
CN¥21.42
7D
8.7%
1Y
18.3%
Walvax Biotechnology
Market Cap: CN¥16.2b
Researches, develops, produces, and markets vaccines in China.
300142
CN¥10.14
7D
-2.3%
1Y
-29.2%
CSPC Innovation Pharmaceutical
Market Cap: CN¥61.2b
Engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally.
300765
CN¥41.88
7D
-0.3%
1Y
24.5%
Mabwell (Shanghai) Bioscience
Market Cap: CN¥9.1b
A biopharmaceutical company, engages in the research and development, manufacture, and commercialization of biological products in China and internationally.
688062
CN¥21.89
7D
10.8%
1Y
-38.5%
Nanjing Vazyme Biotech
Market Cap: CN¥8.9b
Offers technology solutions for life science, biomedicine, and in vitro diagnostics.
688105
CN¥22.57
7D
-7.6%
1Y
-14.9%
GemPharmatech
Market Cap: CN¥4.5b
A contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide.
688046
CN¥11.31
7D
3.6%
1Y
-8.3%